Marriage Counselors in South Windsor, CT Accepting Medicare

26 Marriage Counselors found. Showing 21 - 26

Miss Eva Tarnawski, M.A. Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 1738 Ellington Rd, South Windsor, CT 06074 Phone: 860-916-1621

Lindsay Betzendahl, MA, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 1750 Ellington Rd, Building 3, South Windsor, CT 06074 Phone: 860-808-6959

Mrs. Jessemyn Esther Pekari, MFT Marriage & Family Therapist Medicare: Medicare Enrolled Practice Location: 239 Graham Rd, South Windsor, CT 06074 Phone: 860-221-4761

Mrs. Nancy J Carter, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 7 Hillside Drive Unit 1, South Windsor, CT 06074 Phone: 860-798-5522

Mrs. Helen Hahn Fisher, M.S. Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 435 Buckland Rd, South Windsor, CT 06074 Phone: 860-966-9589

Angela Koehnke, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 225 Oakland Rd, Ste 403, South Windsor, CT 06074 Phone: 860-644-3222    Fax: 860-644-9730

News Archive

Research shows over 50% of tumors have mutations in p53

Researchers of the Cancer Metabolism group at the Bellvitge Biomedical Research Institute (IDIBELL), Catalan Oncology Institute (ICO) and the Division of Hematology-Oncology of the University of Cincinnati, led by George Thomas, have discovered a role for ribosomal 5S RNA in the formation of a complex that regulates the stability of p53.

Shutdown spurs relitigation of Obamacare

Editors at the prestigious New England Journal of Medicine urge the nation's physicians to make their views on the health law known to their congressional representatives, noting their own favorable stance, while a conservative Georgia district urges the House GOP to keep up its fight to defund the law.

FDA approves advanced malignant melanoma drug

Maxim Pharmaceuticals today announced that its treatment protocol to provide its investigational drug Ceplene(TM), in combination with interleukin-2 (IL-2), for the treatment of patients with advanced malignant melanoma, has been approved by the U.S. Food and Drug Administration (FDA).

Update from SemBioSys Genetics regarding Botaneco Specialty Ingredients

SemBioSys Genetics Inc. today announced that Advitech Inc. ("Advitech") has entered into a definitive agreement to acquire all of the issued and outstanding shares of Botaneco Specialty Ingredients Inc. ("Botaneco") held by SemBioSys and Avrio Ventures Limited Partnership ("Avrio").

Magnetic nano tweezers show how cancer drug works

The annoying bulges of an over-wound telephone cord that shorten its reach and limit a caller's motion help to explain why drugs called camptothecins are so effective in killing cancer cells, according to investigators at St. Jude Children's Research Hospital and Delft University of Technology.

Read more Medical News

› Verified 2 days ago

• 1
• 2(current)